Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.

Cancer research and treatment - 1 Apr 2022

Yoon Sang Eun, Kim Yeon Jeong, Shim Joon Ho, Park Donghyun, Cho Junhun, Ko Young Hyeh, Park Woong-Yang, Mun Yeung-Chul, Lee Kyoung Eun, Cho Duck, Kim Won Seog, Kim Seok Jin

Abstract excerpt

PURPOSE: Analysis of circulating tumor DNA (ctDNA) in blood could allow noninvasive genetic analysis of primary tumors. Although there have been unmet needs for noninvasive methods in patients with primary central nervous system lymphoma (PCNSL), it is still not determined whether plasma ctDNA analysis could be useful for patients with PCNSL. MATERIALS AND METHODS: Targeted deep sequencing of 54 genes was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Central Nervous System

Share to Circulating Tumor DNA

Share to CNS Lymphoma Diagnosis and Treatment

Share to High-Throughput Nucleotide Sequencing

Share to Lymphoma

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 34325497
DOI: 10.4143/crt.2021.752
PMCID: PMC9016302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.PMID 34325497Read ↗

Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world studySemantic proximity Read ↗

Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.Semantic proximity Read ↗

Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphomaSemantic proximity Read ↗

Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from central nervous system lymphomas patients using next generation sequencingSemantic proximity Read ↗

Circulating tumor DNA assisting lymphoma genetic feature profiling and identification.Semantic proximity Read ↗

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.Semantic proximity Read ↗

Primary CNS lymphoma commonly expresses immune response biomarkersSemantic proximity Read ↗

A rapid genotyping panel for detection of primary central nervous system lymphoma.Semantic proximity Read ↗

The emerging role of circulating tumor DNA in brain tumor researchSemantic proximity Read ↗

Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.Semantic proximity Read ↗

Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes.Semantic proximity Read ↗

[Circulating Tumor DNA Analysis in Lymphomas].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.